SAC Capital Advisors’s DexCom DXCM Stock Holding History

SAC Capital Advisors’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-53,328	Closed	-$551K	–	309
2014 Q1	$551K	Buy	+53,328	New	+$551K	﹤0.01%	1155

Other funds holding DXCM

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

FCM

Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

WRF

Waddell & Reed Financial Overland Park, Kansas $48.6B AUM 84.78% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SAC Capital Advisors's DXCM Position: Q2 2014 in Review

SAC Capital Advisors sold out of DexCom (DXCM) in Q2 2014, closing a stake of 53,328 shares — an estimated $551K sold.

SAC Capital Advisors first reported a position in DXCM in Q1 2014 and held it in 1 quarter. The position peaked at $551K in Q1 2014. 190 funds tracked by Wall St. Rank hold DXCM as of Q2 2014.

SAC Capital Advisors reported no remaining DexCom position as of Q2 2014 after selling out during the quarter.
SAC Capital Advisors sold 53,328 DexCom shares in Q2 2014, an estimated $551K.
SAC Capital Advisors first reported a position in DexCom in Q1 2014 and held it in 1 quarter.
SAC Capital Advisors's DexCom position peaked at $551K in Q1 2014.
190 funds tracked by Wall St. Rank held DexCom as of Q2 2014.

Based on SAC Capital Advisors's 13F filing for Q2 2014.